Week In Review: China Cord Blood Receives Higher Takeover Offer
Deals and Financings Nanjing Xinjiekou Department Store Co. made an unsolicited offer of “not less than” $966 million to buy China Cord Blood Corp. (NYSE: CO), a cord blood banking and stem cell processing company (see story). In April, Golden Meditech (HK: 801), China Cord Blood’s major owner, made a $771 million offer to take…